Skip to main content
SpringerLink
Log in

Radiographic Imaging

  • Chapter
Pancreatic Masses

  • 1127 Accesses

Abstract

For the radiological investigation of the various pancreatic masses, there is a wide variety of available imaging modalities, such as computed tomography (CT), magnetic resonance imaging (MRI), ultrasonography (US), and nuclear medicine. In this chapter, a short overview of these techniques with an emphasis on recent advances will be presented, followed by a practical diagnostic imaging algorithm. Finally, the imaging features of the most common solid, such as pancreatic ductal adenocarcinoma (PDAC) and pancreatic neuroendocrine tumor (PNET), and cystic pancreatic lesions [such as serous cystic adenoma (SCA), mucinous cystic neoplasm (MCN), and intraductal papillary mucinous neoplasm (IPMN)] will be illustrated.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Tempero MA, Arnoletti JP, Behrman SW, Ben-Josef E, Benson 3rd AB, Casper ES, et al. National Comprehensive Cancer Networks. Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2012;10:703–13.

    PubMed Central  CAS  PubMed  Google Scholar 

  2. Schueller G, Schima W, Schueller-Weidekamm C, Weber M, Stift A, Gnant M, et al. Multidetector CT of pancreas: effects of contrast material flow rate and individualized scan delay on enhancement of pancreas and tumor contrast. Radiology. 2006;241:441–8.

    Article  PubMed  Google Scholar 

  3. Prokesch RW, Chow LC, Beaulieu CF, Nino-Murcia M, Mindelzun RE, Bammer R, et al. Local staging of pancreatic carcinoma with multi-detector row CT: use of curved planar reformations initial experience. Radiology. 2002;225:759–65.

    Article  PubMed  Google Scholar 

  4. Horton KM, Fishman EK. Volume-rendered 3D CT of the mesenteric vasculature: normal anatomy, anatomic variants, and pathologic conditions. Radiographics. 2002;22:161–72.

    Article  PubMed  Google Scholar 

  5. Horton KM. Multidetector CT, and three-dimensional imaging of the pancreas: state of the art. J Gastrointest Surg. 2002;6:126–8.

    Article  PubMed  Google Scholar 

  6. Horton KM, Fishman EK. Multidetector CT angiography of pancreatic carcinoma: part 2, evaluation of venous involvement. AJR Am J Roentgenol. 2002;178:833–6.

    Article  PubMed  Google Scholar 

  7. Horton KM, Fishman EK. Multidetector CT angiography of pancreatic carcinoma: part I, evaluation of arterial involvement. AJR Am J Roentgenol. 2002;178:827–31.

    Article  PubMed  Google Scholar 

  8. Kambadakone AR, Sahani DV. Body perfusion CT: technique, clinical applications, and advances. Radiol Clin North Am. 2009;47:161–78. doi:10.1016/j.rcl.2008.11.003.

    Article  PubMed  Google Scholar 

  9. Tirkes T, Menias CO, Sandrasegaran K. MR imaging techniques for pancreas. Radiol Clin North Am. 2012;50:379–93. doi:10.1016/j.rcl.2012.03.003.

    Article  PubMed  Google Scholar 

  10. Le Bihan D. Molecular diffusion, tissue microdynamics and microstructure. NMR Biomed. 1995;8:375–86.

    Article  PubMed  Google Scholar 

  11. Koh DM, Collins DJ, Orton MR. Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges. AJR Am J Roentgenol. 2011;196:1351–61. doi:10.2214/AJR.10.5515.

    Article  PubMed  Google Scholar 

  12. Song HK, Dougherty L. Dynamic MRI with projection reconstruction and KWIC processing for simultaneous high spatial and temporal resolution. Magn Reson Med. 2004;52:815–24.

    Article  PubMed  Google Scholar 

  13. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999;10:223–32.

    Article  CAS  PubMed  Google Scholar 

  14. Sandrasegaran K. Functional MR, imaging of the abdomen. Radiol Clin North Am. 2014;52:883–903. doi:10.1016/j.rcl.2014.02.018.

    Article  PubMed  Google Scholar 

  15. Badea R, Seicean A, Diaconu B, Stan-Iuga R, Sparchez Z, Tantau M, et al. Contrast-enhanced ultrasound of the pancreas—a method beyond its potential or a new diagnostic standard? J Gastrointestin Liver Dis. 2009;18:237–42.

    PubMed  Google Scholar 

  16. Kitano M, Kudo M, Sakamoto H, Komaki T. Endoscopic ultrasonography and contrast-enhanced endoscopic ultrasonography. Pancreatology. 2011;11 Suppl 2:28–33. doi:10.1159/000323493.

    Article  PubMed  Google Scholar 

  17. van Essen M, Sundin A, Krenning EP, Kwekkeboom DJ. Neuroendocrine tumours: the role of imaging for diagnosis and therapy. Nat Rev Endocrinol. 2014;10:102–14. doi:10.1038/nrendo.2013.246.

    Article  PubMed  Google Scholar 

  18. Rufini V, Baum RP, Castaldi P, Treglia G, De Gaetano AM, Carreras C, et al. Role of PET/CT in the functional imaging of endocrine pancreatic tumors. Abdom Imaging. 2012;37:1004–20. doi:10.1007/s00261-012-9871-9.

    Article  PubMed  Google Scholar 

  19. Nensa F, Beiderwellen K, Heusch P, Wetter A. Clinical applications of PET/MR: current status and future perspectives. Diagn Interv Radiol. 2014;20(5):438–47. doi:10.5152/dir.14008.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Schima W, Függer R, Schober E, Oettl C, Wamser P, Grabenwöger F, et al. Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT. AJR Am J Roentgenol. 2002;179:717–24.

    Article  PubMed  Google Scholar 

  21. Schima W, Ba-Ssalamah A, Goetzinger P, Scharitzer M, Koelblinger C. State-of-the-art magnetic resonance imaging of pancreatic cancer. Top Magn Reson Imaging. 2007;18:421–9. doi:10.1097/rmr.0b013e31816459e0.

    Article  PubMed  Google Scholar 

  22. Sahani DV, Kambadakone A, Macari M, Takahashi N, Chari S, Fernandez-del Castillo C. Diagnosis and management of cystic pancreatic lesions. AJR Am J Roentgenol. 2013;200:343–54. doi:10.2214/AJR.12.8862.

    Article  PubMed  Google Scholar 

  23. Berland LL, Silverman SG, Gore RM, Mayo-Smith WW, Megibow AJ, Yee J, et al. Managing incidental findings on abdominal CT: white paper of the ACR Incidental Findings Committee. J Am Coll Radiol. 2010;7:754–73. doi:10.1016/j.jacr.2010.06.013.

    Article  PubMed  Google Scholar 

  24. Tanaka M, Fernández-del Castillo C, Adsay V, Chari S, Falconi M, Jang JY, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12:183–97. doi:10.1016/j.pan.2012.04.004.

    Article  PubMed  Google Scholar 

  25. Del Chiaro M, Verbeke C, Salvia R, Klöppel G, Werner J, McKay C, et al. European experts’ consensus statement on cystic tumours of the pancreas. Dig Liver Dis. 2013;45:703–11. doi:10.1016/j.dld.2013.01.010.

    Article  PubMed  Google Scholar 

  26. Macari M, Lee T, Kim S, Jacobs S, Megibow AJ, Hajdu C, et al. Is gadolinium necessary for MRI follow-up evaluation of cystic lesions in the pancreas? Preliminary results. AJR Am J Roentgenol. 2009;192:159–64. doi:10.2214/AJR.08.1068.

    Article  PubMed  Google Scholar 

  27. Nougaret S, Reinhold C, Chong J, Escal L, Mercier G, Fabre JM, et al. Incidental pancreatic cysts: natural history and diagnostic accuracy of a limited serial pancreatic cyst MRI protocol. Eur Radiol. 2014;24:1020–9. doi:10.1007/s00330-014-3112-2.

    Article  PubMed  Google Scholar 

  28. Saif MW. Pancreatic neoplasm in 2011: an update. JOP. 2011;12:316–21.

    PubMed  Google Scholar 

  29. Oberg K. Pancreatic endocrine tumors. Semin Oncol. 2010;37:594–618. doi:10.1053/j.seminoncol.2010.10.014.

    Article  PubMed  Google Scholar 

  30. Horton KM, Fishman EK. Adenocarcinoma of the pancreas: CT imaging. Radiol Clin North Am. 2002;40:1263–72.

    Article  PubMed  Google Scholar 

  31. Miller FH, Rini NJ, Keppke AL. MRI of adenocarcinoma of the pancreas. AJR Am J Roentgenol. 2006;187:W365–74.

    Article  PubMed  Google Scholar 

  32. Kim JH, Park SH, Yu ES, Kim MH, Kim J, Byun JH, et al. Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations. Radiology. 2010;257:87–96. doi:10.1148/radiol.10100015.

    Article  PubMed  Google Scholar 

  33. Prokesch RW, Schima W, Chow LC, Jeffrey RB. Multidetector CT of pancreatic adenocarcinoma: diagnostic advances and therapeutic relevance. Eur Radiol. 2003;13:2147–54.

    Article  PubMed  Google Scholar 

  34. Valls C, Andía E, Sanchez A, Fabregat J, Pozuelo O, Quintero JC, et al. Dual-phase helical CT of pancreatic adenocarcinoma: assessment of resectability before surgery. AJR Am J Roentgenol. 2002;178:821–6.

    Article  PubMed  Google Scholar 

  35. Coakley FV, Hanley-Knutson K, Mongan J, Barajas R, Bucknor M, Qayyum A. Pancreatic imaging mimics: part 1, imaging mimics of pancreatic adenocarcinoma. AJR Am J Roentgenol. 2012;199:301–8. doi:10.2214/AJR.11.7907.

    Article  PubMed  Google Scholar 

  36. Ichikawa T, Sou H, Araki T, Arbab AS, Yoshikawa T, Ishigame K, et al. Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology. 2001;221:107–16.

    Article  CAS  PubMed  Google Scholar 

  37. Sahani DV, Sainani NI, Deshpande V, Shaikh MS, Frinkelberg DL, Fernandez-del Castillo C. Autoimmune pancreatitis: disease evolution, staging, response assessment, and CT features that predict response to corticosteroid therapy. Radiology. 2009;250:118–29. doi:10.1148/radiol.2493080279.

    Article  PubMed  Google Scholar 

  38. Lu N, Feng XY, Hao SJ, Liang ZH, Jin C, Qiang JW, et al. 64-slice CT perfusion imaging of pancreatic adenocarcinoma and mass-forming chronic pancreatitis. Acad Radiol. 2011;18:81–8. doi:10.1016/j.acra.2010.07.012.

    Article  PubMed  Google Scholar 

  39. Kim JH, Lee JM, Park JH, Kim SC, Joo I, Han JK, et al. Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment—a preliminary study. Radiology. 2013;266:185–96. doi:10.1148/radiol.12120111.

    Article  PubMed  Google Scholar 

  40. Fattahi R, Balci NC, Perman WH, Hsueh EC, Alkaade S, Havlioglu N, et al. Pancreatic diffusion-weighted imaging (DWI): comparison between mass-forming focal pancreatitis (FP), pancreatic cancer (PC), and normal pancreas. J Magn Reson Imaging. 2009;29:350–6. doi:10.1002/jmri.21651.

    Article  PubMed  Google Scholar 

  41. Lee SS, Byun JH, Park BJ, Park SH, Kim N, Park B, et al. Quantitative analysis of diffusion-weighted magnetic resonance imaging of the pancreas: usefulness in characterizing solid pancreatic masses. J Magn Reson Imaging. 2008;28:928–36. doi:10.1002/jmri.21508.

    Article  PubMed  Google Scholar 

  42. Klauss M, Lemke A, Grünberg K, Simon D, Re TJ, Wente MN, et al. Intravoxel incoherent motion MRI for the differentiation between mass forming chronic pancreatitis and pancreatic carcinoma. Invest Radiol. 2011;46:57–63. doi:10.1097/RLI.0b013e3181fb3bf2.

    Article  PubMed  Google Scholar 

  43. Kang KM, Lee JM, Yoon JH, Kiefer B, Han JK, Choi BI. Intravoxel incoherent motion diffusion-weighted MR imaging for characterization of focal pancreatic lesions. Radiology. 2014;270:444–53. doi:10.1148/radiol.13122712.

    Article  PubMed  Google Scholar 

  44. Imdahl A, Nitzsche E, Krautmann F, Högerle S, Boos S, Einert A, et al. Evaluation of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose for the differentiation of chronic pancreatitis and pancreatic cancer. Br J Surg. 1999;86:194–9.

    Article  CAS  PubMed  Google Scholar 

  45. Lee TY, Kim MH, do Park H, Seo DW, Lee SK, Kim JS, et al. Utility of 18F-FDG PET/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer. AJR Am J Roentgenol. 2009;193:343–8. doi:10.2214/AJR.08.2297.

    Article  PubMed  Google Scholar 

  46. Ozaki Y, Oguchi K, Hamano H, Arakura N, Muraki T, Kiyosawa K, et al. Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography. J Gastroenterol. 2008;43:144–51. doi:10.1007/s00535-007-2132-y.

    Article  CAS  PubMed  Google Scholar 

  47. Herwick S, Miller FH, Keppke AL. MRI of islet cell tumors of the pancreas. AJR Am J Roentgenol. 2006;187:W472–80.

    Article  PubMed  Google Scholar 

  48. Gallotti A, Johnston RP, Bonaffini PA, Ingkakul T, Deshpande V, Fernández-del Castillo C, et al. Incidental neuroendocrine tumors of the pancreas: MDCT findings and features of malignancy. AJR Am J Roentgenol. 2013;200:355–62. doi:10.2214/AJR.11.8037.

    Article  PubMed  Google Scholar 

  49. Poultsides GA, Huang LC, Chen Y, Visser BC, Pai RK, Jeffrey RB, et al. Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis. Ann Surg Oncol. 2012;19:2295–303. doi:10.1245/s10434-012-2305-7.

    Article  PubMed  Google Scholar 

  50. Sheth S, Hruban RK, Fishman EK. Helical CT of islet cell tumors of the pancreas: typical and atypical manifestations. AJR Am J Roentgenol. 2002;179:725–30.

    Article  PubMed  Google Scholar 

  51. Kawamoto S, Shi C, Hruban RH, Choti MA, Schulick RD, Fishman EK, et al. Small serotonin-producing neuroendocrine tumor of the pancreas associated with pancreatic duct obstruction. AJR Am J Roentgenol. 2011;197:W482–8. doi:10.2214/AJR.10.5428.

    Article  PubMed  Google Scholar 

  52. Schmid-Tannwald C, Schmid-Tannwald CM, Morelli JN, Neumann R, Haug AR, Jansen N, et al. Comparison of abdominal MRI with diffusion-weighted imaging to 68Ga-DOTATATE PET/CT in detection of neuroendocrine tumors of the pancreas. Eur J Nucl Med Mol Imaging. 2013;40:897–907. doi:10.1007/s00259-013-2371-5.

    Article  CAS  PubMed  Google Scholar 

  53. de Herder WW, Kwekkeboom DJ, Valkema R, Feelders RA, van Aken MO, Lamberts SW, et al. Neuroendocrine tumors and somatostatin: imaging techniques. J Endocrinol Invest. 2005;28(11 Suppl International):132–6.

    PubMed  Google Scholar 

  54. Christ E, Wild D, Forrer F, Brändle M, Sahli R, Clerici T, et al. Glucagon-like peptide-1 receptor imaging for localization of insulinomas. J Clin Endocrinol Metab. 2009;94:4398–405. doi:10.1210/jc.2009-1082.

    Article  CAS  PubMed  Google Scholar 

  55. d’Assignies G, Couvelard A, Bahrami S, Vullierme MP, Hammel P, Hentic O, et al. Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology. 2009;250:407–16. doi:10.1148/radiol.2501080291.

    Article  PubMed  Google Scholar 

  56. Wang Y, Chen ZE, Yaghmai V, Nikolaidis P, McCarthy RJ, Merrick L, et al. Diffusion-weighted MR imaging in pancreatic endocrine tumors correlated with histopathologic characteristics. J Magn Reson Imaging. 2011;33(5):1071–9. doi:10.1002/jmri.22541.

    Article  PubMed  Google Scholar 

  57. Jang KM, Kim SH, Lee SJ, Choi D. The value of gadoxetic acid-enhanced and diffusion-weighted MRI for prediction of grading of pancreatic neuroendocrine tumors. Acta Radiol. 2014;55:140–8. doi:10.1177/0284185113494982.

    Article  PubMed  Google Scholar 

  58. Bhosale PR, Menias CO, Balachandran A, Tamm EP, Charnsangavej C, Francis IR, et al. Vascular pancreatic lesions: spectrum of imaging findings of malignant masses and mimics with pathologic correlation. Abdom Imaging. 2013;38:802–17. doi:10.1007/s00261-012-9954-7.

    Article  PubMed  Google Scholar 

  59. Fernández-del Castillo C, Warshaw AL. Cystic tumors of the pancreas. Surg Clin North Am. 1995;75:1001–16.

    PubMed  Google Scholar 

  60. Sarr MG, Murr M, Smyrk TC, Yeo CJ, Fernandez-del-Castillo C, Hawes RH, et al. Primary cystic neoplasms of the pancreas. Neoplastic disorders of emerging importance—current state-of-the-art and unanswered questions. J Gastrointest Surg. 2003;7:417–28.

    Article  PubMed  Google Scholar 

  61. Choi JY, Kim MJ, Lee JY, Lim JS, Chung JJ, Kim KW, et al. Typical and atypical manifestations of serous cystadenoma of the pancreas: imaging findings with pathologic correlation. AJR Am J Roentgenol. 2009;193:136–42. doi:10.2214/AJR.08.1309.

    Article  PubMed  Google Scholar 

  62. Barral M, Soyer P, Dohan A, Laurent V, Hoeffel C, Fishman EK, et al. Magnetic resonance imaging of cystic pancreatic lesions in adults: an update in current diagnostic features and management. Abdom Imaging. 2014;39:48–65. doi:10.1007/s00261-013-0048-y.

    Article  PubMed  Google Scholar 

  63. Chu LC, Singhi AD, Hruban RH, Fishman EK. Characterization of pancreatic serous cystadenoma on dual-phase multidetector computed tomography. J Comput Assist Tomogr. 2014;38:258–63. doi:10.1097/RCT.10.1097/RCT.0b013e3182ab1556.

    Article  PubMed Central  PubMed  Google Scholar 

  64. Takeshita K, Kutomi K, Takada K, Kohtake H, Furui S, Takada T, et al. Unusual imaging appearances of pancreatic serous cystadenoma: correlation with surgery and pathologic analysis. Abdom Imaging. 2005;30:610–5.

    Article  CAS  PubMed  Google Scholar 

  65. Mottola JC, Sahni VA, Erturk SM, Swanson R, Banks PA, Mortele KJ. Diffusion-weighted MRI of focal cystic pancreatic lesions at 3.0-Tesla: preliminary results. Abdom Imaging. 2012;37:110–7. doi:10.1007/s00261-011-9737-6.

    Article  PubMed  Google Scholar 

  66. Khurana B, Mortelé KJ, Glickman J, Silverman SG, Ros PR. Macrocystic serous adenoma of the pancreas: radiologic-pathologic correlation. AJR Am J Roentgenol. 2003;181:119–23.

    Article  PubMed  Google Scholar 

  67. Dewhurst CE, Mortele KJ. Cystic tumors of the pancreas: imaging and management. Radiol Clin North Am. 2012;50:467–86. doi:10.1016/j.rcl.2012.03.001.

    Article  PubMed  Google Scholar 

  68. Visser BC, Yeh BM, Qayyum A, Way LW, McCulloch CE, Coakley FV. Characterization of cystic pancreatic masses: relative accuracy of CT and MRI. AJR Am J Roentgenol. 2007;189:648–56.

    Article  PubMed  Google Scholar 

  69. Procacci C, Carbognin G, Accordini S, Biasiutti C, Guarise A, Lombardo F, et al. CT features of malignant mucinous cystic tumors of the pancreas. Eur Radiol. 2001;11:1626–30.

    Article  CAS  PubMed  Google Scholar 

  70. Crippa S, Salvia R, Warshaw AL, Domínguez I, Bassi C, Falconi M, et al. Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg. 2008;247:571–9. doi:10.1097/SLA.0b013e31811f4449.

    Article  PubMed Central  PubMed  Google Scholar 

  71. Goh BK, Tan YM, Chung YF, Chow PK, Cheow PC, Wong WK, et al. A review of mucinous cystic neoplasms of the pancreas defined by ovarian-type stroma: clinicopathological features of 344 patients. World J Surg. 2006;30:2236–45.

    Article  PubMed  Google Scholar 

  72. Nadig SN, Pedrosa I, Goldsmith JD, Callery MP, Vollmer CM. Clinical implications of mucinous nonneoplastic cysts of the pancreas. Pancreas. 2012;41:441–6. doi:10.1097/MPA.0b013e318229b9b8.

    Article  PubMed  Google Scholar 

  73. Sarr MG, Kendrick ML, Nagorney DM, Thompson GB, Farley DR, Farnell MB. Cystic neoplasms of the pancreas: benign to malignant epithelial neoplasms. Surg Clin North Am. 2001;81:497–509.

    Article  CAS  PubMed  Google Scholar 

  74. Balci NC, Semelka RC. Radiologic features of cystic, endocrine and other pancreatic neoplasms. Eur J Radiol. 2001;38:113–9.

    Article  CAS  PubMed  Google Scholar 

  75. Chalian H, Töre HG, Miller FH, Yaghmai V. CT attenuation of unilocular pancreatic cystic lesions to differentiate pseudocysts from mucin-containing cysts. JOP. 2011;12:384–8.

    PubMed  Google Scholar 

  76. Procacci C, Megibow AJ, Carbognin G, Guarise A, Spoto E, Biasiutti C, et al. Intraductal papillary mucinous tumor of the pancreas: a pictorial essay. Radiographics. 1999;19:1447–63.

    Article  CAS  PubMed  Google Scholar 

  77. Pedrosa I, Boparai D. Imaging considerations in intraductal papillary mucinous neoplasms of the pancreas. World J Gastrointest Surg. 2010;2:324–30. doi:10.4240/wjgs.v2.i10.324.

    Article  PubMed Central  PubMed  Google Scholar 

  78. Arakawa A, Yamashita Y, Namimoto T, Tang Y, Tsuruta J, Kanemitsu K, et al. Intraductal papillary tumors of the pancreas. Histopathologic correlation of MR cholangiopancreatography findings. Acta Radiol. 2000;41:343–7.

    Article  CAS  PubMed  Google Scholar 

  79. Irie H, Honda H, Aibe H, Kuroiwa T, Yoshimitsu K, Shinozaki K, et al. MR cholangiopancreatographic differentiation of benign and malignant intraductal mucin-producing tumors of the pancreas. AJR Am J Roentgenol. 2000;174:1403–8.

    Article  CAS  PubMed  Google Scholar 

  80. Choi BS, Kim TK, Kim AY, Kim KW, Park SW, Kim PN, et al. Differential diagnosis of benign and malignant intraductal papillary mucinous tumors of the pancreas: MR cholangiopancreatography and MR angiography. Korean J Radiol. 2003;4:157–62.

    Article  PubMed Central  PubMed  Google Scholar 

  81. Maire F, Voitot H, Aubert A, Palazzo L, O’Toole D, Couvelard A, et al. Intraductal papillary mucinous neoplasms of the pancreas: performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy. Am J Gastroenterol. 2008;103:2871–7. doi:10.1111/j.1572-0241.2008.02114.x.

    Article  PubMed  Google Scholar 

  82. Werner JB, Bartosch-Härlid A, Andersson R. Cystic pancreatic lesions: current evidence for diagnosis and treatment. Scand J Gastroenterol. 2011;46:773–88. doi:10.3109/00365521.2011.551892.

    Article  PubMed  Google Scholar 

  83. Manfredi R, Graziani R, Motton M, Mantovani W, Baltieri S, Tognolini A, et al. Main pancreatic duct intraductal papillary mucinous neoplasms: accuracy of MR imaging in differentiation between benign and malignant tumors compared with histopathologic analysis. Radiology. 2009;253:106–15. doi:10.1148/radiol.2531080604.

    Article  PubMed  Google Scholar 

  84. Waters JA, Schmidt CM, Pinchot JW, White PB, Cummings OW, Pitt HA, et al. CT vs MRCP: optimal classification of IPMN type and extent. J Gastrointest Surg. 2008;12:101–9.

    Article  PubMed  Google Scholar 

  85. Akisik MF, Sandrasegaran K, Aisen AA, Maglinte DD, Sherman S, Lehman GA. Dynamic secretin-enhanced MR cholangiopancreatography. Radiographics. 2006;26:665–77.

    Article  PubMed  Google Scholar 

  86. Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, et al. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2007;246:932–7; discussion 937–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Medical Imaging and Technology, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, and Department of Radiology, Karolinska University Hospital, C1-46, KS Huddinge, Stockholm, 14186, Sweden

    Nikolaos Kartalis

  2. Division of Surgery, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, and Centre for Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden

    Johannes Matthias Löhr

Authors
  1. Nikolaos Kartalis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Johannes Matthias Löhr
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nikolaos Kartalis .

Editor information

Editors and Affiliations

  1. Division of Gastroenterology, University of Florida, Gainesville, Florida, USA

    Mihir S. Wagh

  2. Division of Gastroenterology, University of Florida, Gainesville, Florida, USA

    Peter V. Draganov

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Kartalis, N., Löhr, J.M. (2016). Radiographic Imaging. In: Wagh, M., Draganov, P. (eds) Pancreatic Masses. Springer, Cham. https://doi.org/10.1007/978-3-319-19677-0_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-19677-0_7

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-19676-3

  • Online ISBN: 978-3-319-19677-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation